# Peptide Virtual Screening Manual

## Introduction
This is a guide and summary of the work I (Bryan Crampton 17') did, with
direction from Professor Spaller, from October 2016 to June 2017.

The work is an extension of the that done in
[Chemically Modified Peptide Scaffolds Target the CFTR-Associated Ligand PDZ Domain](http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0103650).
Their study demonstrated the potential of developing novel CAL-PDZ peptide
inhibitors by coupling organic acids to a Lysine amino acid inserted into
varying positions of the
[iCAL36](http://onlinelibrary.wiley.com/doi/10.1002/anie.201005575/full) peptide
sequence: ANSRWPTSII. It was determined that the P(-1) residueâ€“â€“counting from
the right, starting at P(0)â€“â€“tolerated these modifications best. In fact, every
acid modification coupled to Lysine at the P(-1) position demonstrated a greater
binding affinity to CAL-PDZ than iCAL36 itself. These peptides were
ANSRWPTS[Ac-K]I, ANSRWPTS[BB-K]I, ANSRWPTS[FB-K]I, and ANSRWPTS[Tfa-K]I.

Based on this proof of concept, my project aimed to take the screening process
for these modified peptides *in silico* due to the time consuming and costly
process of synthesizing and purifying peptides, as well as running binding
assays. Additionally, these are not standard peptides and require a [modified
synthesis procedure](LINK TO MY PROTOCOL). The protocol which I used to
virtually screen these modified peptides is described below.

I ended up using the SchrÃ¶dinger
[Small-Molecule Drug Discovery Suite](https://www.schrodinger.com/suites/small-molecule-drug-discovery-suite)
for this process due to it's comprehensive capability to manipulate the
peptides, as well as run docking and solvation simulation models. The process
for Glide SP-PEP docking, followed by Prime MM-GBSA simulation was taken from
[Improved Docking of Polypeptides with Glide](http://pubs.acs.org/doi/abs/10.1021/ci400128m)
which demonstrated its accuracy compared to competitorsâ€“â€“58% success rate with
docked poses having a RMSD â‰¤ 2.0 Ã… compared to the crystal structure.
This software is commercial and requires a license to use. During my work, I had
near unlimited access to jobs through a trial that has expired, however the
[Norris Cotten Cancer](http://cancer.dartmouth.edu/researchers.html) recently
purchased a limited license.

The primary other software considered for use
was [Rosetta's](https://www.rosettacommons.org)
[FlexPepDock](https://www.rosettacommons.org/docs/latest/application_documentation/docking/flex-pep-dock)
â€“â€“ an open source alternative. It excels at determining correct docked poses
of peptides by sequence. In our case, however, we know the general docked
conformation of the iCAL36 derivatives which vary only in the region of
modification. Essentially, we want to keep most of the peptide backbone
reasonably fixed and only allow the varied region to move freely in space to
identify the lowest-energy pose. This is not FlexPepDock's strength, but can
be easily achieved through ShcÃ¶dinger's Glide. Whether or not this would have
been possible to achieve with FlexPepDock was not investigated Assumedly it
could be with enough work, given that the software is open source.

## SchrÃ¶dinger Software Setup
### Installation
Create an account with [SchrÃ¶dinger](https://www.schrodinger.com) and download
the Small-Molecule-Drug-Discovery-Suite for your OS
[here](https://www.schrodinger.com/downloads/releases). Follow the installation
instructions included in the download. Generally it just requires run
`./INSTALL` from the unarchived download folder. It is assumed that this is
being run on a unix-based OS (macOS or linux), but everything should be
relatively similar on Windows. Wherever you decide to install the software
(default is `~/schrodinger/suites2017-1/`), please add it to your `~/.bashrc`
or `~/.zshrc` so that `$SCHRODINGER` can be accessed anywhere in terminal. This
can be acheived by appending the following line:
```bash
export SCHRODINGER="/opt/schrodinger/suites2017-1/"
```

### Execution Method
#### [Maestro](https://www.schrodinger.com/maestro)
In this process, it will be explained how to run all jobs via the visual
interface. This can be accessed via your Applications folder (macOS) or by
running `$SCHRODINGER/maestro` in terminal.

#### Bash Execution
All jobs that are run can easily be executed via command line, however it is
much easier to run them visuallyâ€“â€“especially since the library enumeration step
requires visual selection of attachment atoms anyway.
  Note: The command line equivalents for each job can be accessed in the job's logs via the **Job Monitor** utility
  located in the **Jobs** tab in the upper right hand corner of the **maestro**
interface.

All jobs can be accessed from the **Tasks** tab in the upper right hand corner
of the **maestro** interface.



## Preparation for Peptide Screening
#### Protein Structure Preparation
1. Open up the crystal structure for the protein of interest (`4NMO` for CAL PDZ)
1. Run the **Protein Preparation Wizard** from the *Tasks* tab
1. Run the `Preprocess` job on the *Import and Process* tab with the desired
parametersâ€“â€“can be left with default values
1. Click `Analyze Workspace` on the *Review and Modify* tab
1. Click `View Problems...` and resolve any problems in the recommended
fashion. Usually these are issues with missing heavy atoms in the crystal
structure, but which are known to be in the amino acid sequence. The default
recommendation to fix each problem can generally be used.
1. Run `Optimize` on the *Refine* tab (or `Interactive Optimizer...` if
desired to view each recommended fix before proceeding). This will use basic
optimization to recommend flips in rotation of bonds for particular residuesâ€“â€“
often *His*, *Asn*, and *Gln*.
1. If desired, a restrained energy minimization of the structure can also be
performed by running `Minimize` also on the *Refine* tab. This is limited
to a specified RMSD for each atom and was used for refining both CAL and GIPC.
1. A new structure will appear in the **Entry List** after each job. The most recent
(bottom of the list) structure can be renamed something useful, and the remaining
intermediary prep structures can be discarded.
1. If additional solvent / ions still persist in the prepared protein structure
which are undesired, they may be removed at this step by expanding the structure
in the **Structure Hierarchy** window (bottom left) and selecting solvents or other
ions.
1. Expand the *Protein* entry, in the **Structure Hierarchy** window,
and select the chain corresponding to the peptide ligand. Right click
this entry, click `Extract to new entry`, and name it something different. Now
you have a separate protein + solvent and peptide structures.
1. If the peptide docked in the crystal structure does not have *Lys* in the
position where acid-coupling is desired, you must first mutate that residue.
This can be achieved simply by selecting the residue, right clicking one of the
atoms, then hovering over `Mutate Residue` and selecting *Lys*. In
the case of CAL PDZ, `4NMO` has the docked sequence `RWPTSK(Ac)I` which already
has *Lys* at P(-1). For GIPC, the docked sequence `QSTYSEA` required mutation of
P(-1) from *Glu* to *Lys*.
1. The protein and peptide structures have now been prepared for receptor
grid generation and library enumeration.

#### Glide Receptor Grid Generation
1. Ensure just the protein and peptide are displayed in the workspace
1. Run the **Receptor Grid Generation** from the *Tasks* tab
1. When prompted, select an atom on the peptide ligand
1. Check the box for "Generate grid suitable for peptide docking"
1. The remaining parameters may be added or fine-tuned on the remaining tabs.
However, I have not changed any default values during my screens. I experimented
with adding H-bond and positional constraints, however I opted not to use them.
They overly constrained the system and added computational time to satisfy all
the constraints. Instead I used core-RMSD constraints as described in **Peptide
Screening** below.
1. Click `Run`. The output flies will be saved to your current working directory
in **maestro**.

#### Acid Library Preparation
1. Run **Reagent Preparation** from the *Tasks* tab
1. Open the input carboxylic acid library in `.mae`, `.sdf`, `.mol`, or `.smi`
format
1. Select the functional group to identify. Fpr carboxylic acid / *Lys*
coupling, I used the `Carboxylic_Acid_C_O` functional group. This essentially
removes the `-OH` group from the acid for attachment to the terminal amine group
on *Lys*.
1. The remaining parameters may be left in their default values or fine-tuned.
It is important that "Treatment of multiple occurrences" be set to "Produce a
structure only if all are equivalent" or "Ignore the molecule" in order to
maintain selective synthesizability.
1. Click `Run`. The output flies will be saved to your current working directory
in **maestro**.

#### Peptide-Acid Library Enumeration
1. Ensure just the peptide entry is displayed in the workspace
1. Run **Combinatorial Library Enumeration** from the *Tasks* tab
1. Select an atom on the peptide and click `OK` on the pop-up
1. Now select the terminal *Nitrogen* atom on the *Lys* residue which is to be
modified, then select one of the *Hydrogens* attached to it. A blue arrow
indicating the acid-attachment position should be displayed
1. In the file-browser pop-up, select the `.bld` file located within the output
folder from the **Reagent Preparation** run (in the working directory for
**maestro**).
1. The remaining parameters may be left in their default values. Make sure that
"Untangle and minimize structures" is checked. This will change the
conformation of the enumerated peptidesâ€“â€“compared to the crystal structureâ€“â€“but
this does not matter since the docking constraints will realign the atoms to the
docked pose of the unmodified peptide.
1. Click `Run`. The output flies will be saved to your current working directory
in **maestro**.
1. Optionally, if you wish to dock the unmodified peptide (with and/or without
a *Lys* mutation), you can merge those structures into the output file. Import
the output file from the enumeration run into **maestro**. Next, duplicate the
additional peptides to be screened the same group (right click entry â€“â€“>
`Duplicate` â€“â€“> `Into Existing Group`). Then export the entire group of peptides
to be docked into a single file (select the group and right click â€“â€“> `Export`
â€“â€“> `Structures` and enter a filename. This output file should be selected in
**Peptide Screening** section below.


## Google Cloud Engine and VPN Setup (optional)
### Usage
Use of Google Cloudâ€“â€“specifically Google Compute Engine (GCE) is really only
necessary for the screening partâ€“â€“Glide docking and Prime MMGBSA simulation.
Preparation and library enumeration jobs take reasonable amounts of time on a
normal computer.

### Creation and Setup Automation
Under the `Google Cloud` directory, there are various scripts to automate the
creation and setup of a number of GCE instances. They are all rather simple,
and simply demonstrate the ability to automate these task with relative ease.
They utilize basic bash commands as well as the gcloud sdk, which must be
[installed](https://cloud.google.com/sdk/downloads). The
[gcloud reference](https://cloud.google.com/sdk/gcloud/reference/)
provides detailed explanations of all parameters for these commands. The scripts
are documented and can be investigated as needed. The general protocol to run
these scripts is outlined below. It is assumed all commands are executed within
the `Google Cloud` directory.

#### Requirements
1. A local installation of the [SchrÃ¶dinger Software Setup](SchrÃ¶dinger-Software-Setup)
1. A local installation of the [gcloud SDK](https://cloud.google.com/sdk/downloads)
initialized with an active Google Cloud account (run `gloud init` and sign in)
1. A custom `researcher-5-9-17` image on your Google Cloud Console with the
SchrÃ¶dinger software pre-installed. A `researcher-5-9-17.raw.gz` file should be
provided. This can be uploaded to Google Cloud storage bucket. An image on GCE
can then be created using this bucket URL. Details on this process can be found
[here](https://cloud.google.com/compute/docs/images/create-delete-deprecate-private-images)
or within `image-disk.sh`. This image can be further customized, but has latest
version of SchrÃ¶dinger, a vncserver library, and other various dependencies
installed: python 2.7, Chrome Remote Desktop, etc. It is a derivative of Ubuntu.

#### Instance Creation
1. Customize the `zones`, `cpu_counts`, and `memory_counts` variables in
`create-instances.sh`. These were maxed out to the quotas at the time (for my
GCE account). CPU quotas are described [here](https://cloud.google.com/compute/quotas)
and custom machine types (maximum memory per CPU ratio) is outlined [here](https://cloud.google.com/compute/docs/instances/creating-instance-with-custom-machine-type).
  - **Side Note**: I have always used the maximum amount of memory per CPU that
  is possible. This is because the Glide docking jobs are extremely memory
  intensive. I additionally create virtual swap-memoryâ€“â€“preventing crashing when
  the instances run out of memory (which happens often). That being said, the
  Prime MMGBSA simulations are not very memory intensive and it would probably
  be cheaper to use lower-memory instances for these jobs.
1. Run `./create-instances.sh` and watch to ensure no errors occur
1. Verify the instances have been created on [Google Cloud Console](https://console.cloud.google.com/compute/instances)

#### Instance Setup
1. Ensure the machine you are currently on has access to the network in which
the SchÃ¶dinger license server is located (either physical or via VPN).
1.

Run this job on a computer within a network which has access to the SchrÃ¶dinger
license server. Replace `LICENSE_SERVER_URL` in the line below with the provider
server URL. Replace `username` with the user login for the remote GCE instance,
and `IP.ADDRESS` with the instance's external IP address.

`
ssh -o "StrictHostKeyChecking no" -nfNT -R 27008:LICENSE_SERVER_URL:27008
-R 53000:LICENSE_SERVER_URL:53000 username@IP.ADDRESS
`


## Peptide Screening ðŸ”Ž ðŸ’Š
#### Glide Docking
1. Ensure just the protein and unmodified peptide are displayed in the workspace
1. Run the **Ligand Docking** from the *Tasks* tab
1. Under the *Ligands* tab, select the output file from **Combinatorial
Library Enumeration** run.
1. Under the *Settings* tab, set "Precision" to `SP-Peptide`
1. Under the *Core* tab, check "Use core pattern comparison" and "Pick core-
containing molecule"
1. Select an atom on the unmodified peptide (should be almost exactly aligned
to the crystal structure, except if one of the residues had to be mutated to
*Lys*).
1. Select the "SMARTS pattern" radio-box
1. In the workspace, select the entire peptide minus all of the atoms on the
*Lys* residue which will have modifications on it. The selection has to be
connectedâ€“â€“i.e. the alpha-carbon must be selectedâ€“â€“but the entire "R" group
does not have to be. During my runs, I also included the hydrogens on the
backbone in this selection, but that is not required either. This pattern
represents the atoms which are fixed in space during the docking procedure and
can be modified as desired. The "Tolerance" I used during my screens was 0.5
Ã….
1. The remaining parameters may be left in their default values or fine-tuned.
Constraints generated during **Receptor Grid Generation** may be selected under
the *Constraints* tab. Torsional constraints also may be applied, however with
the core-pattern comparison on most of the molecule's atoms, the torsional
angles are constrained by nature.
1. Clicking the gear drop down next to "Job name", then `Job Settings` brings up
a panel which allows enabling of distributed jobs.
1. Click `Run` to begin the job which can be monitored through the job-monitor
control panel on the top right of Maestro.

#### Prime MMGBSA Simulation


## References
[@1]: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0103650 "Chemically Modified Peptide Scaffolds Target the CFTR-Associated Ligand PDZ Domain"
[@2]: http://onlinelibrary.wiley.com/doi/10.1002/anie.201005575/full "Engineering Peptide Inhibitors To Overcome PDZ Binding Promiscuity"
